Recognising Colorectal Cancer in Primary Care

被引:0
作者
Natalia Calanzani
Aina Chang
Marije Van Melle
Merel M. Pannebakker
Garth Funston
Fiona M. Walter
机构
[1] University of Cambridge,Primary Care Unit, Department of Public Health and Primary Care
[2] University of Cambridge,School of Clinical Medicine, Addenbrooke’s Hospital
[3] University of Melbourne,Centre for Cancer Research and Department of General Practice
来源
Advances in Therapy | 2021年 / 38卷
关键词
Colorectal cancer; Early diagnosis; Faecal immunochemical test; Primary care;
D O I
暂无
中图分类号
学科分类号
摘要
Colorectal cancer (CRC) is the third most common cancer worldwide. Primary care professionals can play an important role in both prevention and early detection of CRC. Most CRCs are attributed to modifiable lifestyle factors, which can be addressed within primary care, and promotion of population-based screening programmes can aid early cancer detection in asymptomatic patients. Primary care professionals have a vital role in clinically assessing patients presenting with symptoms that may indicate cancer, as most patients with CRC first present with symptoms. These assessments are often challenging—many of the symptoms of CRC are non-specific and commonly occur in patients presenting with non-malignant disease. The range of options for investigating symptomatic patients in primary care is rapidly growing. Simple tests, such as faecal immunochemical testing (FIT), are now being used to guide decisions around referral for more invasive tests, such as colonoscopy, while direct access to specialist investigations is also becoming more common. Clinical decision support tools (CDSTs) which calculate cancer risk based on symptomatology, patient characteristics and test results can provide an additional resource to guide decisions on further investigation. This article explores the challenges of CRC prevention and detection from the primary care perspective, discusses current evidence-based approaches for CRC detection used in primary care (with examples from UK guidelines), and highlights emerging research which may likely alter practice in the future.
引用
收藏
页码:2732 / 2746
页数:14
相关论文
共 269 条
[1]  
Arnold M(2020)Global burden of 5 major types of gastrointestinal cancer Gastroenterology 159 335-49.e15
[2]  
Abnet CC(2013)Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000–2007 Acta Oncol 52 919-932
[3]  
Neale RE(2015)The expanding role of primary care in cancer control Lancet Oncol 16 1231-1272
[4]  
Maringe C(2014)The role of primary care in early detection and follow-up of cancer Nat Rev Clin Oncol 11 38-48
[5]  
Walters S(2018)Reimagining the diagnostic pathway for gastrointestinal cancer Nat Rev Gastroenterol Hepatol 15 181-188
[6]  
Rachet B(2019)The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 Lancet Gastroenterol Hepatol 4 913-933
[7]  
Rubin G(2018)Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States CA Cancer J Clin 68 31-54
[8]  
Berendsen A(2018)The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015 Br J Cancer 118 1130-1141
[9]  
Crawford SM(2019)Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years Gut 68 1820-1826
[10]  
Emery JD(2017)Colorectal cancer incidence patterns in the United States, 1974–2013 J Natl Cancer Inst 109 djw322-518